F
F. Laurie
Researcher at Quality Assurance Review Center
Publications - 20
Citations - 243
F. Laurie is an academic researcher from Quality Assurance Review Center. The author has contributed to research in topics: Radiation therapy & Breast cancer. The author has an hindex of 5, co-authored 20 publications receiving 225 citations. Previous affiliations of F. Laurie include University of Massachusetts Medical School.
Papers
More filters
Journal ArticleDOI
Effect of Addition of Adjuvant Paclitaxel on Radiotherapy Delivery and Locoregional Control of Node-Positive Breast Cancer: Cancer and Leukemia Group B 9344
Carolyn I. Sartor,Bercedis L. Peterson,Susan Woolf,Thomas J. Fitzgerald,F. Laurie,Andrew J. Turrisi,Jeff Bogart,I. Craig Henderson,Larry Norton +8 more
TL;DR: Despite the delay to RT during additional chemotherapy, adjuvant AC+T afforded better local control than AC alone in patients treated with breast-conserving therapy.
Journal ArticleDOI
Hyperfractionated radiation in children with rhabdomyosarcoma—Results of an intergroup rhabdomyosarcoma pilot study
Sarah S. Donaldson,Lina Asmar,John C. Breneman,Chris Fryer,Arvin S. Glicksman,F. Laurie,Moody D. Wharam,Edmund A. Gehan +7 more
TL;DR: The IRS IV-P study confirms that HF XRT combined with chemotherapy is both feasible and tolerable in children with rhabdomyosarcoma, and was feasible treatment in a multiinstitutional study.
Journal ArticleDOI
Impact of high-dose chemotherapy on the ability to deliver subsequent local-regional radiotherapy for breast cancer: analysis of Cancer and Leukemia Group B Protocol 9082.
Lawrence B. Marks,Lawrence B. Marks,Constance Cirrincione,Thomas J. Fitzgerald,Thomas J. Fitzgerald,F. Laurie,Arvin S. Glicksman,James J. Vredenburgh,Leonard R. Prosnitz,Elizabeth J. Shpall,Michael Crump,Paul G. Richardson,Michael W. Schuster,Jinli Ma,Jinli Ma,Bercedis L. Peterson,Larry Norton,Steven Seagren,I. Craig Henderson,David D. Hurd,William P. Peters +20 more
TL;DR: Patients randomized to HD-CPB were less likely to initiate RT, and of those who did, they were more likely to have RT interrupted, modified, and terminated earlier than those randomized to ID- CPB.
Journal ArticleDOI
Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.
Thomas J. Fitzgerald,Maryann Bishop-Jodoin,David S Followill,James M. Galvin,Michael V. Knopp,Jeff M. Michalski,Mark A. Rosen,Jeffrey D. Bradley,Lalitha K. Shankar,F. Laurie,M. Giulia Cicchetti,Janaki Moni,C. Norman Coleman,James A. Deye,Jacek Capala,Bhadrasain Vikram +15 more
TL;DR: Integration of imaging and radiation oncology data acquisition, review, management, and archive strategies are essential for trial compliance and future research.
Journal ArticleDOI
Treatment Toxicity: Radiation
Thomas J. Fitzgerald,Maryann Bishop-Jodoin,F. Laurie,Alexander Lukez,Lauren O'Loughlin,Allison Sacher +5 more
TL;DR: Current knowledge concerning normal tissue tolerance with therapy is reviewed, and acute and late effects of radiation treatment and how the fingerprints of therapy can have an impact on health care in later life are reviewed.